News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment [CME/CPE

Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care Organizations

ByJeffrey D. Dunn, PharmD, MBA,Nancy A. Nickman, PhD

May 8th 2012

Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment

By

May 8th 2012

Participating Faculty: Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment

By

May 7th 2012

Clinical and Humanistic Aspects of Growth Hormone Deficiency and Growth-Related Disorders

ByAlan D. Rogol, MD, PhD

May 7th 2012

Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan Setting

ByNancy A. Nickman, PhD,Jeffrey D. Dunn, PharmD, MBA

May 7th 2012

Trending on AJMC

Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol

Improving Patient-Centered Cardiovascular Care for Older Adults

Mitigate Treatment Burden in Heart Failure: Martha Gulati, MD

Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD

Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.